| Name | Title | Contact Details |
|---|
Chimerix is a biopharmaceutical company dedicated to discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients. Chimerix`s proprietary lipid conjugate technology has produced brincidofovir (BCV, CMX001); CMX157, which was licensed to ContraVir Pharmaceuticals; and earlier-stage clinical candidates. Chimerix recently announced a new clinical candidate, CMX521, for the treatment and/or prevention of norovirus.
RxCeutical is a Richmond, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Pharmacy Examination Board of Canada is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
X-37 is a pharmaceutical discovery and development company